Page last updated: 2024-08-23

deoxynivalenol and Hepatocellular Carcinoma

deoxynivalenol has been researched along with Hepatocellular Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdul, NS; Chuturgoon, AA; Ghazi, T; Nagiah, S; Ndlovu, S1
Didier, A; Dietrich, R; Lippke, H; Märtlbauer, E; Nielsen, C1

Other Studies

2 other study(ies) available for deoxynivalenol and Hepatocellular Carcinoma

ArticleYear
Deoxynivalenol downregulates NRF2-induced cytoprotective response in human hepatocellular carcinoma (HepG2) cells.
    Toxicon : official journal of the International Society on Toxinology, 2021, Apr-15, Volume: 193

    Topics: Antioxidants; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Trichothecenes

2021
Potential of deoxynivalenol to induce transcription factors in human hepatoma cells.
    Molecular nutrition & food research, 2009, Volume: 53, Issue:4

    Topics: Activating Transcription Factor 3; Carcinoma, Hepatocellular; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Gene Expression Profiling; Humans; Liver Neoplasms; MAP Kinase Signaling System; Mycotoxins; Transcription Factors; Trichothecenes

2009
chemdatabank.com